type 1 diabetes glp-1 In patients with residual ß-cell function, treatment GLP-1s may lower risk for

Change is definitely coming, but not in the way you think

As conversations around GLP-1 medications continue to grow, its important to reframe how we think about weight management

But that hasn't stopped companies from selling GLP-1-specific training programs, meal plans, hormone supplements and protein shakes trying to capitalize on the panic over GLP-1 muscle loss

New users of GLP-1RAs were matched based on age, demographics, comorbidities and medication use by using 1:1 propensity matching with other glucose-lowering drugs

GLP-1 receptor agonists like semaglutide have shown protective effects on kidney function in multiple clinical trials, particularly for people with type 2 diabetes

Gastrointestinal symptoms such as nausea, constipation, and indigestion are most common and usually subside as your body adjusts